385 related articles for article (PubMed ID: 34709120)
1. N6-methyladenosine reader YTH N6-methyladenosine RNA binding protein 3 or insulin like growth factor 2 mRNA binding protein 2 knockdown protects human bronchial epithelial cells from hypoxia/reoxygenation injury by inactivating p38 MAPK, AKT, ERK1/2, and NF-κB pathways.
Xiao K; Liu P; Yan P; Liu Y; Song L; Liu Y; Xie L
Bioengineered; 2022 May; 13(5):11973-11986. PubMed ID: 34709120
[TBL] [Abstract][Full Text] [Related]
2. N6-methyladenosine reader YTHDF3 regulates melanoma metastasis via its 'executor'LOXL3.
Shi HZ; Xiong JS; Gan L; Zhang Y; Zhang CC; Kong YQ; Miao QJ; Tian CC; Li R; Liu JQ; Zhang EJ; Bu WB; Wang Y; Cheng XF; Sun JF; Chen H
Clin Transl Med; 2022 Nov; 12(11):e1075. PubMed ID: 36324258
[TBL] [Abstract][Full Text] [Related]
3. RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner.
Yu D; Pan M; Li Y; Lu T; Wang Z; Liu C; Hu G
J Exp Clin Cancer Res; 2022 Jan; 41(1):6. PubMed ID: 34980207
[TBL] [Abstract][Full Text] [Related]
4. IGF2BP2 promotes the progression of ovarian endometriosis by regulating m6A-modified MEIS2 and GATA6.
Zhao S; Zhang B; Yuan H; Yin Y; Qi S; Li W; Wu X; Yaling F
Int J Biochem Cell Biol; 2022 Nov; 152():106296. PubMed ID: 36113831
[TBL] [Abstract][Full Text] [Related]
5. IGF2BP2 knockdown suppresses thyroid cancer progression by reducing the expression of long non-coding RNA HAGLR.
Dong L; Geng Z; Liu Z; Tao M; Pan M; Lu X
Pathol Res Pract; 2021 Sep; 225():153550. PubMed ID: 34340128
[TBL] [Abstract][Full Text] [Related]
6. m6A methylated EphA2 and VEGFA through IGF2BP2/3 regulation promotes vasculogenic mimicry in colorectal cancer via PI3K/AKT and ERK1/2 signaling.
Liu X; He H; Zhang F; Hu X; Bi F; Li K; Yu H; Zhao Y; Teng X; Li J; Wang L; Zhang Y; Wu Q
Cell Death Dis; 2022 May; 13(5):483. PubMed ID: 35595748
[TBL] [Abstract][Full Text] [Related]
7. m
Ruan P; Wang S; Yang C; Huang X; Sun P; Tan A
Cell Biol Toxicol; 2023 Aug; 39(4):1611-1626. PubMed ID: 35971034
[TBL] [Abstract][Full Text] [Related]
8. MiR-324/SOCS3 Axis Protects Against Hypoxia/Reoxygenation-Induced Cardiomyocyte Injury and Regulates Myocardial Ischemia via TNF/NF-κB Signaling Pathway.
Han X; Chen X; Han J; Zhong Y; Li Q; An Y
Int Heart J; 2020 Nov; 61(6):1258-1269. PubMed ID: 33191336
[TBL] [Abstract][Full Text] [Related]
9. The m6A reader IGF2BP2 promotes the progression of esophageal squamous cell carcinoma cells by increasing the stability of OCT4 mRNA.
Zhao R; Li T; Zhao X; Yang Z; Ma L; Wang X
Biochem Cell Biol; 2024 Apr; 102(2):169-178. PubMed ID: 37917979
[TBL] [Abstract][Full Text] [Related]
10. Involvement of m6A regulatory factor IGF2BP1 in malignant transformation of human bronchial epithelial Beas-2B cells induced by tobacco carcinogen NNK.
Zhou J; Xiong R; Zhou J; Guan X; Jiang G; Chen Y; Yang Q
Toxicol Appl Pharmacol; 2022 Feb; 436():115849. PubMed ID: 34974052
[TBL] [Abstract][Full Text] [Related]
11. FTO knockdown alleviates hypoxia-induced PC12 cell injury by stabilizing GADD45B in an IGF2BP2-dependent manner.
Wang D; Li Y; Xu X; Zhao S; Wang Z; Yang J; Zhang X; Pan J; Wang Y; Liu M
Biochem Biophys Res Commun; 2022 Sep; 619():166-172. PubMed ID: 35803057
[TBL] [Abstract][Full Text] [Related]
12. Aspirin inhibits p44/42 mitogen-activated protein kinase and is protective against hypoxia/reoxygenation neuronal damage.
Vartiainen N; Goldsteins G; Keksa-Goldsteine V; Chan PH; Koistinaho J
Stroke; 2003 Mar; 34(3):752-7. PubMed ID: 12624303
[TBL] [Abstract][Full Text] [Related]
13. [Hypoxia/reoxygenation and lipopolysaccharide induced nuclear factor-ΚB and hypoxia-inducible factor-1α signaling pathways in intestinal epithelial cell injury and the interventional effect of emodin].
Qi L; Yuan B; Fu Q
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Jun; 26(6):409-14. PubMed ID: 24912640
[TBL] [Abstract][Full Text] [Related]
14. Methylation recognition protein YTH N6-methyladenosine RNA binding protein 1 (YTHDF1) regulates the proliferation, migration and invasion of osteosarcoma by regulating m6A level of CCR4-NOT transcription complex subunit 7 (CNOT7).
Wei K; Gao Y; Wang B; Qu YX
Bioengineered; 2022 Mar; 13(3):5236-5250. PubMed ID: 35156522
[TBL] [Abstract][Full Text] [Related]
15. [Characteristics of N6-methyladenosine modification patterns in t(8;21) acute myeloid leukemia].
Wen Y; Fang S; Yang J; Wang H; Jiao Y; Wang N; Wei Y; Wang L; Dou L
Nan Fang Yi Ke Da Xue Xue Bao; 2022 May; 42(5):690-697. PubMed ID: 35673912
[TBL] [Abstract][Full Text] [Related]
16. The potential role of N6-methyladenosine modification of LncRNAs in contributing to the pathogenesis of chronic glomerulonephritis.
Liu T; Zhuang XX; Qin XJ; Wei LB; Gao JR
Inflamm Res; 2023 Mar; 72(3):623-638. PubMed ID: 36700958
[TBL] [Abstract][Full Text] [Related]
17. CaMKIIδ, Stabilized by RNA N6-Methyladenosine Reader IGF2BP2, Boosts Coxsackievirus B3-Induced Myocardial Inflammation via Interacting with TIRAP.
Xiao Q; Liu L; Qian W; Kang T; Ying R; Nie J
J Cardiovasc Transl Res; 2024 Jan; ():. PubMed ID: 38229002
[TBL] [Abstract][Full Text] [Related]
18. Genetic deletion of PKR abrogates TNF-induced activation of IkappaBalpha kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation.
Takada Y; Ichikawa H; Pataer A; Swisher S; Aggarwal BB
Oncogene; 2007 Feb; 26(8):1201-12. PubMed ID: 16924232
[TBL] [Abstract][Full Text] [Related]
19. Synchronous profiling of mRNA N6-methyladenosine modifications and mRNA expression in high-grade serous ovarian cancer: a pilot study.
Yang L; Liu J; Jin Y; Xing J; Zhang J; Chen X; Yu A
Sci Rep; 2024 May; 14(1):10427. PubMed ID: 38714753
[TBL] [Abstract][Full Text] [Related]
20. The interaction between Toll-like receptor 4 signaling pathway and hypoxia-inducible factor 1α in lung ischemia-reperfusion injury.
Zhou Z; Zhu X; Chen J; Yang S; Sun R; Yang G
J Surg Res; 2014 May; 188(1):290-7. PubMed ID: 24472280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]